Document text
Principal Investigator: Andrew S. Pekosz
Organization: JOHNS HOPKINS UNIVERSITY
Fiscal Year: 2024
Award: $126,658
Funding agency: National Cancer Institute
JH-EPICS Virology Resource Core (VRC) Summary
The Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS) aims to
systematically analyze the innate, T cell, and antibody responses that either protect or cause pathology during
SARS-CoV-2 infection. In order to accurately accomplish the Specific Aims within the three JH-EPICS
Research Projects, a consistent and reliable source of virus-specific reagents and methods is required. The
Virology Resource Core (VRC) is tasked with providing SARS-CoV-2-specific reagents and access to BSL3
facilities to perform experiments with virus infected cells for the three JH-EPICS Research Projects. The VRC
draws on the expertise of Andrew Pekosz, PhD (Lead) and Michael Betenbaugh, PhD (Co-Lead) to generate
these reagents. The VRC will produce recombinant proteins and, in particular, proteins with complex
carbohydrate moieties. The VRC has the ability to use mammalian cells to express small or large quantities of
purified proteins that will be used by all the JH-EPICS Research Projects to measure viral antigen specific
responses. The Lead of the VRC has experience with respiratory viruses, such as influenza, SARS-CoV, and
SARS-CoV-2, which will enable the VRC to rigorously and accurately grow and provide the JH-EPICS
Research Projects with a consistent source of virus particles or infected cell lysates that have been inactivated
and can be used in laboratories outside of BSL3-containment. The VRC will provide the expertise and access
to facilities necessary to perform experiments on virus-infected cells, which will allow the JH-EPICS
investigators to validate results with live virus. The centralized production of these reagents, the use of
standardized protocols for virus infections, and consistent use across JH-EPICS Research Projects will
improve the quality, rigor, and reproducibility of data to increase the public health significance of the JH-EPICS
studies.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV S protein><2019-nCoV spike glycoprotein><2019-nCoV spike protein><Amino Acids><Antibody Response><Assay><BSL-3 facility><BSL3 facility><Bioassay><Biological Assay><COVID surveillance><COVID-19><COVID-19 S protein><COVID-19 infection><COVID-19 spike><COVID-19 spike glycoprotein><COVID-19 spike protein><COVID-19 surveillance><COVID-19 virus><COVID-19 virus infection><COVID19 infection><COVID19 surveillance><COVID19 virus><CV-19><Carbohydrates><Cell Body><Cell Culture Techniques><Cell Line><CellLine><Cells><Clinical><CoV-2><CoV2><Complex><Containment><Coronavirus Infectious Disease 2019><Data><Doctor of Philosophy><Ensure><Generations><Grippe><Immunity><Influenza><International><Investigators><Laboratories><Lead><Mammalian Cell><Measures><Methods><Pathogenesis><Pathology><Pb element><Peptides><Ph.D.><PhD><Plaque Assay><Post-Translational Modification Protein/Amino Acid Biochemistry><Post-Translational Modifications><Post-Translational Protein Modification><Post-Translational Protein Processing><Posttranslational Modifications><Posttranslational Protein Processing><Production><Protein Binding Domain><Protein Binding Motif><Protein Modification><Protein-Protein Interaction Domain><Proteins><Protocol><Protocols documentation><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Reagent><Recombinant Proteins><Reproducibility><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><SARS Virus><SARS corona virus><SARS corona virus 2><SARS coronavirus><SARS-Associated Coronavirus><SARS-CO-V2><SARS-COVID-2><SARS-CoV><SARS-CoV-1><SARS-CoV-2><SARS-CoV-2 S><SARS-CoV-2 S protein><SARS-CoV-2 infection><SARS-CoV-2 spike><SARS-CoV-2 spike glycoprotein><SARS-CoV-2 spike protein><SARS-CoV-2 surveillance><SARS-CoV2><SARS-CoV2 infection><SARS-Related Coronavirus><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Serology><Severe Acute Respiratory Coronavirus><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 S protein><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 spike glycoprotein><Severe acute respiratory syndrome coronavirus 2 spike protein><Severe acute respiratory syndrome related corona virus 2><Source><Standardization><Strains Cell Lines><T-Cells><T-Lymphocyte><Testing><Time><Universities><Viral Antigens><Viral Diseases><Virion><Virus><Virus Diseases><Virus Particle><Work><Wuhan coronavirus><aminoacid><biosafety level 3 facility><cell culture><cell cultures><coronavirus disease 2019><coronavirus disease 2019 S protein><coronavirus disease 2019 infection><coronavirus disease 2019 spike glycoprotein><coronavirus disease 2019 spike protein><coronavirus disease 2019 surveillance><coronavirus disease 2019 virus><coronavirus disease surveillance><coronavirus disease-19><coronavirus disease-19 virus><coronavirus infectious disease-19><cultured cell line><depository><experience><experiment><experimental research><experimental study><experiments><hCoV19><heavy metal Pb><heavy metal lead><improved><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><lab experience><lab training><laboratory experience><laboratory facility><laboratory training><milligram><nCoV2><particle><protein function><protein purification><reagent standardization><receptor binding><receptor bound><repository><respiratory virus><response><severe acute respiratory syndrome coronavirus 2 surveillance><severe acute respiratory syndrome-CoV><spike proteins on SARS-CoV-2><thymus derived lymphocyte><viral RNA><viral infection><virology><virus RNA><virus antigen><virus infection><virus-induced disease>